299 related articles for article (PubMed ID: 15818538)
1. Adjuvant and neoadjuvant therapy in non-small cell lung cancer.
Belani CP
Semin Oncol; 2005 Apr; 32(2 Suppl 2):S9-15. PubMed ID: 15818538
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for non-small-cell lung carcinoma: from a blanket approach to individual therapy.
Reungwetwattana T; Eadens MJ; Molina JR
Semin Respir Crit Care Med; 2011 Feb; 32(1):78-93. PubMed ID: 21500127
[TBL] [Abstract][Full Text] [Related]
3. Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience.
Savic M; Kontic M; Ercegovac M; Stojsic J; Bascarevic S; Moskovljevic D; Kostic M; Vesovic R; Popevic S; Laban M; Markovic J; Jovanovic D
Thorac Cancer; 2017 Sep; 8(5):393-401. PubMed ID: 28671758
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer.
Bernstein ED; Herbert SM; Hanna NH
Ann Surg Oncol; 2006 Mar; 13(3):291-301. PubMed ID: 16450219
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy in stage III NSCLC.
Allen J; Jahanzeb M
J Natl Compr Canc Netw; 2008 Mar; 6(3):285-93. PubMed ID: 18377847
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy in early-stage non-small cell lung cancer.
Edelman MJ
Expert Rev Anticancer Ther; 2001 Aug; 1(2):229-35. PubMed ID: 12113028
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant treatment of lung cancer: current status and potential applications of new regimens.
Le Chevalier T; Lynch T
Lung Cancer; 2004 Dec; 46 Suppl 2():S33-9. PubMed ID: 15698530
[TBL] [Abstract][Full Text] [Related]
8. Systemic and targeted therapies for early-stage lung cancer.
Byron E; Pinder-Schenck M
Cancer Control; 2014 Jan; 21(1):21-31. PubMed ID: 24357738
[TBL] [Abstract][Full Text] [Related]
9. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
Johnson BE; Rabin MS
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
[TBL] [Abstract][Full Text] [Related]
10. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ
Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813
[TBL] [Abstract][Full Text] [Related]
11. [Non-small cell lung cancer (NSCLC): the evolution of neo-adjuvant chemotherapy in the last 15 years].
Santo A; Genestreti G; Fiorio E; Terzi A; Lonardoni A; Calabrò F; Campaldini B; Colaluca P; Molino A; Cetto GL
Recenti Prog Med; 2006 Apr; 97(4):211-8. PubMed ID: 16729492
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant and neoadjuvant chemotherapy in NSCLC: a paradigm shift.
Betticher DC
Lung Cancer; 2005 Dec; 50 Suppl 2():S9-16. PubMed ID: 16557669
[TBL] [Abstract][Full Text] [Related]
13. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
Bunn PA
Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
[TBL] [Abstract][Full Text] [Related]
14. [Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer].
Yamaguchi M; Fukuyama Y; Ichinose Y
Gan To Kagaku Ryoho; 2003 Feb; 30(2):203-8. PubMed ID: 12610867
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
Tieu BH; Sanborn RE; Thomas CR
Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
[TBL] [Abstract][Full Text] [Related]
16. Early-stage non-small-cell lung cancer: adjuvant versus neoadjuvant chemotherapy.
Belani CP
Clin Lung Cancer; 2003 Jul; 5(1):11-2. PubMed ID: 14596696
[No Abstract] [Full Text] [Related]
17. Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial).
Kocher F; Pircher A; Mohn-Staudner A; Romeder F; Duller W; Steinmaurer M; Eckmayr J; Schmid T; Hilbe W; Fiegl M; Greil R
Lung Cancer; 2014 Sep; 85(3):395-400. PubMed ID: 25043642
[TBL] [Abstract][Full Text] [Related]
18. Resectable non-small cell lung cancer Adjuvant chemotherapy: slightly longer survival.
Prescrire Int; 2016 Dec; 25(177):299-301. PubMed ID: 30758927
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy in non-small cell lung cancer.
Le Chevalier T
Semin Oncol; 1998 Aug; 25(4 Suppl 9):62-5. PubMed ID: 9728587
[TBL] [Abstract][Full Text] [Related]
20. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
